Evenity 105 mg/1.17mL
romosozumab-aqqg · INJECTION, SOLUTION · Amgen, Inc
No Recall History
Plain English
Evenity is a injection, solution containing romosozumab-aqqg at 105 mg/1.17mL, taken subcutaneous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- Evenity
- Generic Name
- romosozumab-aqqg
- NDC Code (Product)
55513-509- Manufacturer
- Amgen, Inc
- Strength
- 105 mg/1.17mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761062
- Marketing Start
- 01/09/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Evenity used for?
Evenity contains romosozumab-aqqg. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Evenity a controlled substance?
Evenity is not classified as a controlled substance by the DEA.
What is the generic name for Evenity?
The generic name for Evenity is romosozumab-aqqg. There are no other listed brand versions of romosozumab-aqqg.
What is the NDC code for Evenity 105 mg/1.17mL?
The NDC (National Drug Code) for Evenity 105 mg/1.17mL is 55513-509, listed by Amgen, Inc.
Other Evenity Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)